Knut Pettersson

1.6k total citations
42 papers, 1.3k citations indexed

About

Knut Pettersson is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Surgery. According to data from OpenAlex, Knut Pettersson has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Immunology and 9 papers in Surgery. Recurrent topics in Knut Pettersson's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Antioxidant Activity and Oxidative Stress (7 papers) and Physiological and biochemical adaptations (7 papers). Knut Pettersson is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Antioxidant Activity and Oxidative Stress (7 papers) and Physiological and biochemical adaptations (7 papers). Knut Pettersson collaborates with scholars based in Sweden, Netherlands and Australia. Knut Pettersson's co-authors include Roland Stocker, Stefan Nilsson, Paul K. Witting, Kjell Johansen, Christer Westerlund, Maria Wågberg, Paul H.A. Quax, Margreet R. de Vries, J. Wouter Jukema and Andrew J. Brown and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Scientific Reports.

In The Last Decade

Knut Pettersson

42 papers receiving 1.2k citations

Peers

Knut Pettersson
Marinella Rosselli Switzerland
Julian L. Pakay Australia
Nadeene Parker United Kingdom
Linda Biadasz Clerch United States
Knut Pettersson
Citations per year, relative to Knut Pettersson Knut Pettersson (= 1×) peers Rosa Mazza

Countries citing papers authored by Knut Pettersson

Since Specialization
Citations

This map shows the geographic impact of Knut Pettersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut Pettersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut Pettersson more than expected).

Fields of papers citing papers by Knut Pettersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut Pettersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut Pettersson. The network helps show where Knut Pettersson may publish in the future.

Co-authorship network of co-authors of Knut Pettersson

This figure shows the co-authorship network connecting the top 25 collaborators of Knut Pettersson. A scholar is included among the top collaborators of Knut Pettersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knut Pettersson. Knut Pettersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ståhle, Mia, Johanna M. U. Silvola, Sanna Hellberg, et al.. (2020). Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice. JACC Basic to Translational Science. 5(4). 360–373. 10 indexed citations
2.
Jong, Rob C. M. de, Margreet R. de Vries, Knut Pettersson, et al.. (2020). Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response. JACC Basic to Translational Science. 5(12). 1228–1239. 9 indexed citations
3.
Jong, Rob C. M. de, Margreet R. de Vries, Knut Pettersson, et al.. (2018). Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. Scientific Reports. 8(1). 6753–6753. 34 indexed citations
4.
Caidahl, Kenneth, Marianne Hartford, Thomas Karlsson, et al.. (2012). IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. International Journal of Cardiology. 167(2). 464–469. 38 indexed citations
5.
Pettersson, Knut, M.M. Ewing, Margreet R. de Vries, et al.. (2011). Abstract 15644: A Fully Human Monoclonal IgG Phosphorylcholine Antibody Prevents Accelerated Atherosclerosis in Mice. Circulation. 124. 2 indexed citations
6.
Pettersson, Knut, et al.. (2007). Pulse wave analysis on fingertip arterial pressure: effects of age, gender and stressors on reflected waves and their relation to brachial and femoral artery blood flow. Clinical Physiology and Functional Imaging. 28(2). 86–95. 15 indexed citations
7.
Pettersson, Knut, Martin Kjerrulf, Lennart Jungersten, et al.. (2006). The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism. Atherosclerosis. 196(1). 275–282. 5 indexed citations
8.
Pettersson, Knut, et al.. (2006). N,N‐Diacetyl‐l‐cystine Improves Endothelial Function in Atherosclerotic Watanabe Heritable Hyperlipidaemic Rabbits. Basic & Clinical Pharmacology & Toxicology. 100(1). 36–42. 2 indexed citations
9.
Blomqvist, Maria, Martin Carrier, Knut Pettersson, et al.. (2004). In vivoadministration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats. Diabetes/Metabolism Research and Reviews. 21(2). 158–166. 22 indexed citations
10.
Pettersson, Knut & Håkan Bergstrand. (2003). The Antiatherogenic Effect of DiNAC: Experimental Findings Supporting Immunomodulation as a New Treatment for Atherosclerosis Related Diseases. Cardiovascular Drug Reviews. 21(2). 119–132. 4 indexed citations
11.
Lind, Lars, et al.. (2003). Analysis of endothelium‐dependent vasodilation by use of the radial artery pulse wave obtained by applanation tonometry. Clinical Physiology and Functional Imaging. 23(1). 50–57. 25 indexed citations
12.
Pettersson, Knut, et al.. (2003). Influence of different types of stressors on the waveform of the peripheral arterial pulse in humans. Blood Pressure. 12(5-6). 291–297. 4 indexed citations
13.
Jackson, Christopher L. & Knut Pettersson. (2001). Effects of probucol on rat carotid artery responses to balloon catheter injury. Atherosclerosis. 154(2). 407–414. 16 indexed citations
14.
Witting, Paul K., et al.. (2000). Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radical Biology and Medicine. 29(3-4). 295–305. 85 indexed citations
15.
Witting, Paul K., et al.. (1999). Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. Journal of Clinical Investigation. 104(2). 213–220. 94 indexed citations
16.
Kaplan, Jay R., et al.. (1998). Endothelial injury and leukocyte adherence in Häutchen preparations from coronary arteries and aorta of cynomolgus monkeys. Atherosclerosis. 136(1). 33–42. 2 indexed citations
17.
Pettersson, Knut, et al.. (1992). Inhibition of platelet accumulation by ?1-adrenoceptor blockade in the thoracic aorta of rabbits subjected to experimental sympathetic activation. Cardiovascular Drugs and Therapy. 6(5). 505–511. 7 indexed citations
18.
Hansson, Göran K., et al.. (1990). Smoking, Catecholamines and their Effects on Endothelial Cell Integrity. Advances in experimental medicine and biology. 273. 51–59. 9 indexed citations
19.
Åblad, Bengt, Jan‐Arne Björkman, David Gustafsson, et al.. (1988). The role of sympathetic activity in atherogenesis: Effects of β-blockade. American Heart Journal. 116(1). 322–327. 59 indexed citations
20.
Nilsson, Ove, S. Bööj, Annica Dahlström, et al.. (1988). Sympathetic Innervation of the Cardiovascular System in the Giraffe. Journal of Vascular Research. 25(6). 299–307. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026